Name
Hervinson OÜ
Registry code
12798718
VAT number
EE101804888
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.02.2015 (9)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
4646 - Wholesale of pharmaceutical goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Hervin Jurnas 20.06.1975 (49) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| osaühing MED&DENT 10243809 | 50% - 1 252.00 EUR | - | - |
| 2019 11.11.2020 | 2020 25.06.2021 | 2021 30.06.2022 | 2022 16.05.2023 | |
|---|---|---|---|---|
| Total Revenue | 361 798 € | 613 880 € | 460 985 € | 664 675 € |
| Net profit (loss) for the period | 101 982 € | 150 686 € | 59 728 € | 2 069 € |
| Profit Margin | 28% | 25% | 13% | 0% |
| Current Assets | 53 684 € | 123 506 € | 71 292 € | 19 238 € |
| Fixed Assets | 121 596 € | 187 410 € | 262 831 € | 328 214 € |
| Total Assets | 175 280 € | 310 916 € | 334 123 € | 347 452 € |
| Current Liabilities | 4 392 € | 19 460 € | 13 758 € | 51 040 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 170 888 € | 291 456 € | 320 365 € | 296 412 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 280 453.06 € | 39 123.37 € | 2 029.02 € | - |
| 2023 Q4 | 265 351.76 € | 23 016.25 € | - | - |
| 2023 Q3 | 313 606.68 € | 39 991.75 € | - | - |
| 2023 Q2 | 492 824.67 € | 42 108.27 € | - | - |
| 2023 Q1 | 298 684.38 € | 32 832.16 € | 669.15 € | - |
| 2022 Q4 | 504 065.57 € | 59 177.11 € | - | - |
| 2022 Q3 | 204 131.12 € | 16 603.17 € | - | - |
| 2022 Q2 | 293 127.53 € | 33 683.64 € | 752.69 € | - |
| 2022 Q1 | 355 822.07 € | 32 928.8 € | - | - |
| 2021 Q4 | 260 140.88 € | 26 269.02 € | - | - |
| 2021 Q3 | 96 177.4 € | 10 582.5 € | 536.67 € | - |
| 2021 Q2 | 198 032.7 € | 27 469.48 € | 819.39 € | - |
| 2021 Q1 | 313 187.23 € | 33 894.22 € | - | 1 |
| 2020 Q4 | 242 733.15 € | 24 969.51 € | - | 1 |
| 2020 Q3 | 256 102.63 € | 33 890.73 € | 116.67 € | 1 |
| 2020 Q2 | 263 074.92 € | 29 791.97 € | - | 1 |
| 2020 Q1 | 259 445.13 € | 20 739.07 € | - | 1 |
